BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 16859679)

  • 1. The Fanconi anemia/BRCA pathway: a coordinator of cross-link repair.
    Mirchandani KD; D'Andrea AD
    Exp Cell Res; 2006 Aug; 312(14):2647-53. PubMed ID: 16859679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA interstrand crosslink repair and cancer.
    Deans AJ; West SC
    Nat Rev Cancer; 2011 Jun; 11(7):467-80. PubMed ID: 21701511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disruption of mouse Slx4, a regulator of structure-specific nucleases, phenocopies Fanconi anemia.
    Crossan GP; van der Weyden L; Rosado IV; Langevin F; Gaillard PHL; McIntyre RE; ; Gallagher F; Kettunen MI; Lewis DY; Brindle K; Arends MJ; Adams DJ; Patel KJ
    Nat Genet; 2011 Feb; 43(2):147-52. PubMed ID: 21240276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recurrent Tumefactive Central Nervous System Lesions Due to BRIP1 -Related Fanconi Anemia.
    Nathoo N; Gavrilova RH; Trejo-Lopez JA; McGarrah PW; Go RS; Alqallaf A; Tobin WO
    Neurologist; 2023 Sep; 28(5):332-334. PubMed ID: 37582649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inherited DNA Repair Defects Disrupt the Structure and Function of Human Skin.
    Ruiz-Torres S; Brusadelli MG; Witte DP; Wikenheiser-Brokamp KA; Sauter S; Nelson AS; Sertorio M; Chlon TM; Lane A; Mehta PA; Myers KC; Bedard MC; Pal B; Supp DM; Lambert PF; Komurov K; Kovacic MB; Davies SM; Wells SI
    Cell Stem Cell; 2021 Mar; 28(3):424-435.e6. PubMed ID: 33232662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unpaved roads: How the DNA damage response navigates endogenous genotoxins.
    Thada V; Greenberg RA
    DNA Repair (Amst); 2022 Oct; 118():103383. PubMed ID: 35939975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Planispine A Sensitized Cancer Cells to Cisplatin by Inhibiting the Fanconi Anemia Pathway.
    Singh TD; Singh NI; Devi KM; Meiguilungpou R; Khongsai L; Singh LS; Bal NC; Swapana N; Singh CB; Singh TR
    Molecules; 2022 Oct; 27(21):. PubMed ID: 36364114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A seven-lncRNA signature for predicting prognosis in breast carcinoma.
    Xu M; Chen Z; Lin B; Zhang S; Qu J
    Transl Cancer Res; 2021 Sep; 10(9):4033-4046. PubMed ID: 35116701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perspectives on the role of breast cancer susceptibility gene in breast cancer.
    Wu N; Wei L; Li L; Li F; Yu J; Liu J
    Int J Clin Oncol; 2022 Mar; 27(3):495-511. PubMed ID: 35064849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel five-lncRNA signature panel improves high-risk survival prediction in patients with cholangiocarcinoma.
    Xie X; Wang Y; Zhang S; Li J; Yu Z; Ding X; Ye L; Gong P; Zhu Q; Li J; Chen Z; Yao X; Du Z; Zeng Q; Chen H; Yang Z; Chen G
    Aging (Albany NY); 2021 Jan; 13(2):2959-2981. PubMed ID: 33472169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Both BRCA1-wild type and -mutant triple-negative breast cancers show sensitivity to the NAE inhibitor MLN4924 which is enhanced upon MLN4924 and cisplatin combination treatment.
    Misra S; Zhang X; Wani NA; Sizemore S; Ray A
    Oncotarget; 2020 Feb; 11(8):784-800. PubMed ID: 32166000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acid-specific formaldehyde donor is a potential, dual targeting cancer chemotherapeutic/chemo preventive drug for FANC/BRCA-mutant cancer.
    Ridpath JR; Nakamura J
    Genes Environ; 2019; 41():23. PubMed ID: 31890056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA damage response and cancer therapeutics through the lens of the Fanconi Anemia DNA repair pathway.
    Bhattacharjee S; Nandi S
    Cell Commun Signal; 2017 Oct; 15(1):41. PubMed ID: 29017571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological targeting of RAD6 enzyme-mediated translesion synthesis overcomes resistance to platinum-based drugs.
    Sanders MA; Haynes B; Nangia-Makker P; Polin LA; Shekhar MP
    J Biol Chem; 2017 Jun; 292(25):10347-10363. PubMed ID: 28490629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fanconi anemia-D1 due to homozygosity for the BRCA2 gene Cypriot founder mutation: A case report.
    Loizidou MA; Hadjisavvas A; Tanteles GA; Spanou-Aristidou E; Kyriacou K; Christophidou-Anastasiadou V
    Oncol Lett; 2016 Jan; 11(1):471-473. PubMed ID: 26834852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spontaneous tumor development in bone marrow-rescued DNA-PKcs(3A/3A) mice due to dysfunction of telomere leading strand deprotection.
    Zhang S; Matsunaga S; Lin YF; Sishc B; Shang Z; Sui J; Shih HY; Zhao Y; Foreman O; Story MD; Chen DJ; Chen BP
    Oncogene; 2016 Jul; 35(30):3909-18. PubMed ID: 26616856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene-ethanol interactions underlying fetal alcohol spectrum disorders.
    McCarthy N; Eberhart JK
    Cell Mol Life Sci; 2014 Jul; 71(14):2699-706. PubMed ID: 24554057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The breast cancer susceptibility genes (BRCA) in breast and ovarian cancers.
    Paul A; Paul S
    Front Biosci (Landmark Ed); 2014 Jan; 19(4):605-18. PubMed ID: 24389207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular resistance fingerprint of pemetrexed and platinum in a long-term survivor of mesothelioma.
    Røe OD; Szulkin A; Anderssen E; Flatberg A; Sandeck H; Amundsen T; Erlandsen SE; Dobra K; Sundstrøm SH
    PLoS One; 2012; 7(8):e40521. PubMed ID: 22905093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of Rev1 by the Fanconi anemia core complex.
    Kim H; Yang K; Dejsuphong D; D'Andrea AD
    Nat Struct Mol Biol; 2012 Jan; 19(2):164-70. PubMed ID: 22266823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.